sarepta therapeutics fda

Order byBest matchMost fresh

FDA asks Sarepta to stop shipping gene therapy

Digest more

· 4h

Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request

Facing mounting criticism, Sarepta recently announced plans to add a bold warning label to Elevidys.

· 20h · on MSN

Gene therapy maker Sarepta tells FDA it won't halt shipments despite patient deaths

· 1d

Exclusive: Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys

· 20h

Sarepta tells FDA it won’t halt shipments despite patient deaths

Drugmaker Sarepta Therapeutics said late Friday it won’t comply with a request from the Food and Drug Administration to halt all shipments of its gene therapy following the death of a third patient r...

· 1d

FDA to ask Sarepta to stop shipping Duchenne gene therapy

· 1d

Sarepta Therapeutics crisis is huge blow to Duchenne families, company

GEN33m

StockWatch: Sarepta Shares Nosedive after LGMD Gene Therapy Patient Dies

Late on Friday, Sarepta refused an FDA request to voluntarily halt shipments of Elevidys ... SRP-9004 was originally developed by Myonexus Therapeutics as MYO-102, until Myonexus entered into a collaboration with Sarepta in 2018 to develop that gene ...

Hoodline20h

Sarepta Therapeutics Announces Layoff of 493 Employees, Including 80 in Ohio, Amid FDA Scrutiny and Stock Decline

Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.

1don MSN

Sarepta Shares Crash on Report That FDA Will Ask It to Stop Shipping Key Drug

The drop comes the day after the drugmaker said it would add a so-called black-box warning to its gene therapy Elevidys after two teenage boys receiving the treatment died earlier this year.